These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 8948505

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects.
    Nony P, Ffrench P, Girard P, Delair S, Azoulay S, Girre JP, Dechavanne M, Boissel JP.
    Can J Physiol Pharmacol; 1996 Aug; 74(8):887-93. PubMed ID: 8960377
    [Abstract] [Full Text] [Related]

  • 23. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, Wakao T, Hara T, Mori K, Naruse K, Nakashima W.
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [Abstract] [Full Text] [Related]

  • 24. Effects of beraprost sodium and prostaglandin E1 on skin blood flow in diabetic rats and normal dogs.
    Ueno Y, Yamada N, Koike H, Nishio S.
    Gen Pharmacol; 1996 Mar; 27(2):333-5. PubMed ID: 8919652
    [Abstract] [Full Text] [Related]

  • 25. Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue.
    Hirasawa Y, Nishio M, Maeda K, Yoshida K, Kita Y.
    Eur J Pharmacol; 1995 Jan 05; 272(1):39-43. PubMed ID: 7713147
    [Abstract] [Full Text] [Related]

  • 26. Clinical effect of addition of beraprost sodium to pioglitazone treatment on the blood glucose levels in patients with type 2 diabetes mellitus.
    Chen T, Kusunoki M, Sato D, Tsutsui H, Nakamura T, Miyata T, Oshida Y.
    Exp Clin Endocrinol Diabetes; 2013 Nov 05; 121(10):624-7. PubMed ID: 24002894
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Beneficial action of beraprost sodium, a prostacyclin analog, in stroke-prone rats.
    Stier CT, Chander PN, Belmonte A, Inamdar RS, Mistry M.
    J Cardiovasc Pharmacol; 1997 Sep 05; 30(3):285-93. PubMed ID: 9300310
    [Abstract] [Full Text] [Related]

  • 29. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
    Miyata M, Ueno Y, Sekine H, Ito O, Sakuma F, Koike H, Nishio S, Nishimaki T, Kasukawa R.
    J Cardiovasc Pharmacol; 1996 Jan 05; 27(1):20-6. PubMed ID: 8656653
    [Abstract] [Full Text] [Related]

  • 30. [Research and development of beraprost sodium, a new stable PGI2 analogue].
    Nishio S, Nagase H, Kanou K, Aoki S, Kanbayashi Y.
    Yakugaku Zasshi; 1997 Aug 05; 117(8):509-21. PubMed ID: 9306726
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial.
    Shin S, Kim KJ, Chang HJ, Lee BW, Yang WI, Cha BS, Choi D.
    Diabetes Obes Metab; 2013 Feb 05; 15(2):185-8. PubMed ID: 22974254
    [Abstract] [Full Text] [Related]

  • 33. Protective effect of beraprost sodium, a new chemically stable prostacyclin analogue, against the deterioration of baroreceptor reflex following transient global cerebral ischaemia in dogs.
    Kurihara J, Sahara T, Kato H.
    Br J Pharmacol; 1990 Jan 05; 99(1):91-6. PubMed ID: 2110014
    [Abstract] [Full Text] [Related]

  • 34. A dose-effect study of beraprost sodium in intermittent claudication.
    Lievre M, Azoulay S, Lion L, Morand S, Girre JP, Boissel JP.
    J Cardiovasc Pharmacol; 1996 Jun 05; 27(6):788-93. PubMed ID: 8761844
    [Abstract] [Full Text] [Related]

  • 35. Perfusion lung scan as a prognostic indicator of response to beraprost sodium in idiopathic pulmonary arterial hypertension.
    Park SY, Moon DH, Park YB, Na JO, Whang HK, Lim BS, Lee SD.
    Pulm Pharmacol Ther; 2006 Jun 05; 19(4):264-71. PubMed ID: 16139536
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Beraprost sodium, a prostaglandin I2 analogue, protects against advanced gycation end products-induced injury in cultured retinal pericytes.
    Yamagishi S, Amano S, Inagaki Y, Okamoto T, Takeuchi M, Makita Z.
    Mol Med; 2002 Sep 05; 8(9):546-50. PubMed ID: 12456993
    [Abstract] [Full Text] [Related]

  • 39. Effects of beraprost sodium (Dorner) in patients with diabetes mellitus complicated by chronic arterial obstruction.
    Toyota T, Oikawa S, Beraprost Sodium Study Group.
    Angiology; 2002 Sep 05; 53(1):7-13. PubMed ID: 11863312
    [Abstract] [Full Text] [Related]

  • 40. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
    Nishio S, Kurumatani H.
    Nihon Yakurigaku Zasshi; 2001 Feb 05; 117(2):123-30. PubMed ID: 11233303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.